TIGIT and neoplasm: (143) deleted the protein using CRISPR/Cas9 and observed that knockout resulted in significantly impaired tumor growth, together with increased IFNy secretion and cytotoxicity by NK cells, indicating that tumor cell-intrinsic TIGIT has a considerable effect on tumor growth and may present a potential therapeutic target.